These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7943033)

  • 21. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome.
    Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T
    Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population genetics of fragile X: a multiple allele model with variable risk of CGG repeat expansion.
    Kolehmainen K
    Am J Med Genet; 1994 Jul; 51(4):428-35. PubMed ID: 7943012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservation of CGG region in FMR1 gene in mammals.
    Deelen W; Bakker C; Halley DJ; Oostra BA
    Am J Med Genet; 1994 Jul; 51(4):513-6. PubMed ID: 7943032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.
    Reyniers E; Vits L; De Boulle K; Van Roy B; Van Velzen D; de Graaff E; Verkerk AJ; Jorens HZ; Darby JK; Oostra B
    Nat Genet; 1993 Jun; 4(2):143-6. PubMed ID: 8348152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the gene FMR2, associated with FRAXE mental retardation.
    Gecz J; Gedeon AK; Sutherland GR; Mulley JC
    Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trinucleotide repeat expansions and human genetic disease.
    Bates G; Lehrach H
    Bioessays; 1994 Apr; 16(4):277-84. PubMed ID: 8031305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion.
    Wöhrle D; Hennig I; Vogel W; Steinbach P
    Nat Genet; 1993 Jun; 4(2):140-2. PubMed ID: 8348151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.
    Ashley CT; Sutcliffe JS; Kunst CB; Leiner HA; Eichler EE; Nelson DL; Warren ST
    Nat Genet; 1993 Jul; 4(3):244-51. PubMed ID: 8358432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mosaicism for full mutation and normal-sized allele of the FMR1 gene: a new case.
    Orrico A; Galli L; Dotti MT; Plewnia K; Censini S; Federico A
    Am J Med Genet; 1998 Jul; 78(4):341-4. PubMed ID: 9714436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
    Pomponi MG; Neri G
    Am J Med Genet; 1994 Jul; 51(4):447-50. PubMed ID: 7943015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unstable and methylatable mutations causing the fragile X syndrome.
    Rousseau F; Heitz D; Mandel JL
    Hum Mutat; 1992; 1(2):91-6. PubMed ID: 1301206
    [No Abstract]   [Full Text] [Related]  

  • 33. "Reduction" of CGG trinucleotide expansion from mother to offspring in seven fragile-X families.
    Loesch DZ; Petrovic V; Francis DI; Oertel R; Slater H
    Clin Genet; 1997 Jan; 51(1):1-6. PubMed ID: 9084926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetry of methylation with FMR-1 full mutation in two 45,X/46,XX mosaic females associated with normal intellect.
    Shapiro LR; Simensen RJ; Wilmot PL; Fisch GS; Vibert BK; Fenwick RG; Tarleton J; Phelan MC
    Am J Med Genet; 1994 Jul; 51(4):507-8. PubMed ID: 7943030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of linkage-based DNA-diagnosis of fragile X gene carriers with the CGG repeat probe.
    van Oost BA; Smits AP; Dreesen JC; van den Ouweland AM; Oostra BA
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):320-7. PubMed ID: 1605205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular heterogeneity of the fragile X syndrome.
    Nakahori Y; Knight SJ; Holland J; Schwartz C; Roche A; Tarleton J; Wong S; Flint TJ; Froster-Iskenius U; Bentley D
    Nucleic Acids Res; 1991 Aug; 19(16):4355-9. PubMed ID: 1886762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct analysis of the FMR-1 gene provides an explanation for an exceptional case of a fragile X negative, mentally retarded male in a fragile X family.
    Tarleton J; Wong S; Schwartz C
    J Med Genet; 1992 Dec; 29(12):919-20. PubMed ID: 1336058
    [No Abstract]   [Full Text] [Related]  

  • 38. Fragile X founder effect?
    Chakravarti A
    Nat Genet; 1992 Jul; 1(4):237-8. PubMed ID: 1302018
    [No Abstract]   [Full Text] [Related]  

  • 39. Triplet repeat expansion mutations: the example of fragile X syndrome.
    Warren ST; Ashley CT
    Annu Rev Neurosci; 1995; 18():77-99. PubMed ID: 7605075
    [No Abstract]   [Full Text] [Related]  

  • 40. Concerning the role of X-inactivation and DNA methylation in fragile X syndrome.
    Migeon BR
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):291-8. PubMed ID: 1605203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.